BDRX
Biodexa Pharmaceuticals Plc
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: GBExchange: Nasdaq
Mkt Cap:
Float & O/S:
Inst Own:
DilutionScan read 47 of Biodexa Pharmaceuticals Plc's SEC filings and found 22 warrant series, 1 equity line, 2 shelf registrations, 8 S-1 registrations and 4 completed offerings on file for BDRX. The latest dilution event on file is a registration statement on Sep 30, 2026. Analysis updated Oct 26, 2026.